Combination of PI-RADS score and mRNA urine test—A novel scoring system for improved detection of prostate cancer

Available tests to detect clinically significant prostate cancer frequently lead to overdiagnosis and overtreatment. Our study assessed the feasibility of combining a urinary biomarker-based risk score (SelectMDx(®)) and multiparametric MRI outcomes in order to identify patients with prostate cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Katzendorn, Olga, von Klot, Christoph A. J., Mahjoub, Samy, Faraj Tabrizi, Pouriya, Harke, Nina N., Tezval, Hossein, Hellms, Susanne, Hennenlotter, Jörg, Baig, Mirza S., Stenzl, Arnulf, Seith, Ferdinand, Lafos, Marcel, Kuczyk, Markus A., Rausch, Steffen, Peters, Inga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374213/
https://www.ncbi.nlm.nih.gov/pubmed/35960727
http://dx.doi.org/10.1371/journal.pone.0271981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374213/
https://www.ncbi.nlm.nih.gov/pubmed/35960727
http://dx.doi.org/10.1371/journal.pone.0271981

Ejemplares similares